The website will be down for maintenance on Tuesday 9/19/2017 from 6PM to 8PM Pacific time.

Safety Recommendations for Administering Intravenous Prostacyclins in the Hospital

Author(s): Martha S. Kingman, DNP, FNP-C; Kelly Chin, MD

Contact Hours 1.00

CERP A 1.00

Expires Oct 01, 2017

Topics: Medication Management, Patient Safety, Pulmonary

Population: Adult

Role: Staff

Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Prostacyclins are a high-risk category of continuous intravenous infusions increasingly used in hospitals to treat advanced pulmonary arterial hypertension, a rare condition characterized by vasoconstriction and vascular proliferation of the pulmonary arteries. Prostacyclins are given in doses of nanograms per kilogram per minute and have a narrow therapeutic dosing range for each patient. Sudden increases or decreases in dose can be life threatening. Previous studies revealed errors in the administration of these high-risk infusions, which in some instances led to serious adverse events, including death. We reviewed the literature for safety measures in administration of high-risk intravenous medications and obtained input from leading experts in pulmonary arterial hypertension to create


  • Distinguish between adverse effects of prostacyclins and symptoms of pulmonary artery hypertension
  • Summarize 4 approaches to prevent errors associated with high-risk medications
  • Describe 3 safety recommendations that reduce error during prostacyclin administration

Continuing Education Disclosure Statement

Successful Completion

Learners must attend/view/read the entire activity and complete the associated evaluation to be awarded the contact hours or CERP. No partial credit will be awarded.


This activity has been reviewed by the Nurse Planner. It has been determined that the material presented here shows no bias. Approval of a continuing education activity does not imply endorsement by AACN or ANCC of any commercial products displayed or discussed in conjunction with the activity.


The American Association of Critical-Care Nurses (AACN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC's) Commission on Accreditation, ANCC Provider Number 0012 (60 min contact hour). AACN has been approved as a provider of continuing education in nursing by the California State Board of Registered Nursing, California Provider number CEP1036 contact hours (50 min contact hour).

AACN programming meets the standards for most states that require mandatory continuing education contact hours for license and/or certification renewal. AACN recommends consulting with your state board of nursing or credentialing organization before submitting CE to fulfill continuing education requirements.